Does gefitinib need to be used in combination with other drugs?

Gefitinib is commonly used as monotherapy, specifically to treat patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). In these patients, gefitinib monotherapy has shown significant efficacy, extending survival, reducing symptoms, and improving quality of life. However, sometimes doctors may consider combining gefitinib with other treatments, depending on the patient's condition and treatment needs. Ultimately, decisions about combination therapy should be made by the physician based on the patient's specific circumstances and pathological characteristics. Therefore, if you or someone you know is being treated with gefitinib, you should have a detailed discussion with your doctor to determine the most appropriate treatment option.